Bicara Therapeutics

BICARA THERAPEUTICS INC

Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b.

Bicara Therapeutics Inc

Earnings

Press Releases

Bicara Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

News

General

Bicara Therapeutics Announces Publication of an Abstract with Updated Interim Data from Phase 1/1b Trial of Ficerafusp alfa in 1L R/M HNSCC at the 2025 ASCO Annual Meeting

Health Care

Bicara Therapeutics Demonstrates Deep and Durable Responses with Ficerafusp Alfa Plus Pembrolizumab in 1L HPV-Negative R/M HNSCC at ASCO 2025

Bicara Therapeutics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference

Management

Relay Therapeutics Appoints Claire Mazumdar, Ph.D., to Board of Directors

Omega Funds Closes Oversubscribed $647 Million Fund VIII to Invest in Transformative Life Science Companies

Rice Biotech Launch Pad welcomes Carolyn Ng to external advisory board

Bicara Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update

Bicara Therapeutics to Participate in Upcoming Investor Conferences

Bicara Therapeutics Announces Ficerafusp Alfa Granted Breakthrough Therapy Designation by U.S. FDA for 1L HPV-Negative R/M HNSCC

BBNX

BCAX

BCYC

BOLD

IMGO

KMTS

MORF

RLAY

Arbutus Biopharma Corporation - Common Stock

Arbutus Biopharma

AnaptysBio

Ardelyx

ArriVent BioPharma

BridgeBio Oncology Therapeutics, Inc. - Common Stock

BridgeBio Oncology

CureVac

Dynavax Technologies Corporation - Common Stock

Dynavax Technologies

Geron

Iovance Biotherapeutics, Inc. - Common Stock

Iovance Biotherapeutics

Kura Oncology

MiMedx Group

Precigen

Pharming Group N.V. - ADS, each representing 10 ordinary shares

Pharming

Praxis Precision Medicines, Inc. - Common Stock

Praxis Precision Medicine

Prime Medicine

Palvella Therapeutics, Inc. - Common Stock

Palvella Therapeutics

Relay Therapeutics

Sana Biotechnology

ARS Pharmaceuticals

Tango Therapeutics

Upstream Bio

UroGen Pharma

Valneva

Vir Biotechnology

Xencor

HC Wainwright & Co.

Piper Sandler

Wells Fargo

Cantor Fitzgerald

Wedbush

Comments

Bicara Therapeutics

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL